Christine McCallum (Tina)

Christine (Tina) McCallum has a strong background in project management and drug development. Christine (Tina) currently holds the position of Sr. Director, Project Management at HUTCHMED. Prior to that, they worked at Celgene as Director, Project Management where they successfully executed the project and drug development strategy for early and late stage myeloma programs. Christine (Tina) also has experience as an Associate Director, Project Management at Merck, where they managed multiple development teams and played a key role in the filing of Keytruda, the first FDA-approved cancer treatment based on genetics. In addition, they served as both Franchise Manager and Biomarker Manager for Vaccines and Infectious Diseases at Merck. Earlier in their career, they worked as a Research Fellow at Merck. Overall, Christine McCallum has demonstrated expertise in project management, strategic planning, communication, and team leadership in the pharmaceutical industry.

Christine (Tina) McCallum obtained their PhD in Biochemistry from McMaster University, where they studied from 1989 to 1995. Christine (Tina) also obtained a certification in "Humble Leadership: The Power of Relationships, Openness, and Trust" from LinkedIn in June 2021.